Mucocutaneous leishmaniasis in a patient with the human immunodeficiency virus

Sánchez, Pablo; Gálvez, María Victoria de; Rodrigo, Ana B.; Herrera, Enrique

doi:10.1258/0956462011923804

Cited by 6 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, patients with HIV infection and mucosal leishmaniasis are predisposed to development of atypical lesions. Another constant preoccupation of clinicians is about the risk of mucosal disease become visceral 12–14 . The treatment depends of host, pathogen and direct effect of drug.…”

Section: Discussionmentioning

confidence: 99%

Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil

Tuon

Imamura

et al. 2009

Journal of the European Academy of Dermatology and Venereology

View full text Add to dashboard Cite

The current first-line mucosal leishmaniasis therapy shows an adequate cure but later recurrence. HIV infection and systemic arterial hypertension should be investigated before start the treatment of mucosal leishmaniasis. Conflicts of interest The authors are not part of any associations or commercial relationships that might represent conflicts of interest in the writing of this study (e.g. pharmaceutical stock ownership, consultancy, advisory board membership, relevant patents, or research funding).

show abstract

Section: Discussionmentioning

confidence: 99%

Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil

Tuon

Imamura

et al. 2009

Journal of the European Academy of Dermatology and Venereology

View full text Add to dashboard Cite

show abstract

“…Goh 8 et al in 2004 found it to be three times more common in patients with CD4 counts below 200. Sanchez et al 23 found that 80% of their patient had a CD4 cell count of < 100 cells / cumm. Higher mean CD4 count in current study may be due to the fact that 90% of Pruritic papular eruptions patients were on HAART and it could be due to IRIS (immune reconstitution inflammatory syndrome).…”

Section: Resultsmentioning

confidence: 94%

Cutaneous Manifestations of Hiv-Infection in Relation With Cd4 Cell Counts in Hadoti Region

Jain¹,

Nyati²,

Kumar³

et al. 2013

jemds

View full text Add to dashboard Cite

BACKGROUND: Human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) are frequently associated with mucocutaneous manifestations. However, there is paucity of data on skin disorders and association with CD4 cell counts from India. OBJECTIVE: To evaluate the occurrence of mucocutaneous disorders and their relationship with CD4 count. METHODS: A cross-sectional study was performed at Government Medical College Kota from January 2011 to January 2012. Collected information included demographic data, HIVassociated mucocutaneous disorders, CD4 cell count and highly active antiretroviral therapy (HAART). RESULTS: One hundred cases (male: female, 1.7: 1) were enrolled. The most common mode of HIV transmission was heterosexual (89%), followed by homosexual/bisexual contacts (5%), perinatal (5%) and blood transfusion (1%). The distribution of patients in terms of CD4 cell counts was as follows: 30% with less than 200 × 10 6 /L, 55% with between 200 and 500 × 10 6 /L, and 15% with more than 500× 10 6 /L. Most common skin disorders were fungal infection (46%), followed by bacterial infection (30%), viral infection (26%). Pruritic papular eruption (13%) was most common non infectious dermatoses followed by seborrheic dermatitis (8%). A CD4 cell count of less than 200×10 6 /L was significantly associated with a higher number of mucocutaneous disorders (P = 0.005) and the development of oral candidiasis [P = 0.005] and generalized seborrheic dermatitis (P = 0.005). There was no case of cutaneous malignancy in our study. CONCLUSION: A wide range of mucocutaneous disorders were observed in HIV-infected cases which are the indicator of AIDS and overall survival. A preponderance of infectious and inflammatory dermatoses with an absence of skin tumors characterized this study.

show abstract

Cutaneous Infections Associated with HIV/AIDS

Hogan

2006

Dermatologic Clinics

View full text Add to dashboard Cite

Mucocutaneous leishmaniasis in a patient with the human immunodeficiency virus

Cited by 6 publications

References 5 publications

Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil

Mucosal leishmaniasis: description of case management approaches and analysis of risk factors for treatment failure in a cohort of 140 patients in Brazil

Cutaneous Manifestations of Hiv-Infection in Relation With Cd4 Cell Counts in Hadoti Region

Cutaneous Infections Associated with HIV/AIDS

Contact Info

Product

Resources

About